AQUINOX PHARMACEUTICALS INC's ticker is AQXP and the CUSIP is 03842B101. A total of 53 filers reported holding AQUINOX PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 1.35 and the average weighting 0.1%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 246,877 | $3,143,000 | 0.72% |
| Broadfin Capital, LLC | 510,500 | $6,499,000 | 0.63% |
| SPHERA FUNDS MANAGEMENT LTD. | 190,000 | $2,419,000 | 0.55% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 510,597 | $6,500,000 | 0.20% |
| Baker Brothers Advisors | 1,211,851 | $15,427,000 | 0.20% |
| Perceptive Advisors | 130,000 | $1,655,000 | 0.17% |
| HIGHLAND CAPITAL MANAGEMENT LP | 266,271 | $3,390,000 | 0.14% |
| Visium Asset Management, LP | 298,804 | $3,804,000 | 0.06% |
| Alyeska Investment Group, L.P. | 100,290 | $1,277,000 | 0.04% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 62,387 | $794,000 | 0.03% |